Dr Mercedes Robledo

Mercedes Robledo is the head of the Hereditary Endocrine Cancer Group, at the Spanish National Cancer Research Center (CNIO), Madrid, Spain. She obtained her PhD in cytogenetic and molecular characterization of B-Cell lymphomas by the Autonoma University of Madrid. She was awarded a Postdoctoral Fellowship in 1993 at the Genetic Service of the Fundación Jiménez Díaz. Two years later, she was appointed Associated Researcher at the same institution, focusing her interest on the genetic characterization of patients affected by hereditary endocrine cancer. In 2000 she moved to CNIO and she was also appointed Professor at the Autonoma University. Her research focuses on tumour endocrine familial syndromes, and she has made a substantial contribution to understand the genetic basis of these pathologies. Her group has identified several new genes involved in hereditary pheochromocytomas and paragangliomas, as well as genes responsible for part of the hidden heritability of follicular cell derived thyroid carcinomas. The search of genomic features related to genetic background has allowed her to identify prognostic and diagnostic markers of utility in the clinical setting.   

From 2012 to 2015, Dr. Robledo was the Co-Chair of PRESSOR (The Pheochromocytoma Research Support Organization) Executive Committee, and currently she is a member of the ENS@T Steering Committee (European Network for the Study of adrenal Tumours).

Supported By